SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2252Thanks, Sales. I appreciate your feedback and better understand your thinking nquantman-11/13/2008
2251<My upside wildcard is that one of the HM74a indications would be partnerableBiotech Jim-11/13/2008
2250quantman, 1. thanks for your kind words. 2. during the next 18-24 months, tsoftware salesperson111/13/2008
2249Hello there SSP: 1. Thanks for your excellent write-ups, as always. You are proquantman-11/12/2008
2248<But I’m a black and white person> So you are like Obama then. If you makenhott-11/7/2008
224711/6/08 cc notes 1. from PR FDA granted orphan drug designation for 18424 for software salesperson111/7/2008
2246Incyte's Rheumatoid Arthritis Pill Promising 10/27/08 - 03:32 PM EDT ElizaDoc Bones-10/27/2008
2245Tuck, i listened to the call last nite and found it depressing. in retrospect, software salesperson-10/27/2008
2244Hmm. Dose response a bit muddled? Cheers, Tucktuck-10/27/2008
2243Trying to figure reasons for sell off today on this news, and news of Pfizer'tuck-10/27/2008
2242Pfizer data due Tuesday. Abstract talks about five serious infections. As you scaram(o)uche-10/27/2008
2241link to archived webcast, if anyone needs it quickly (like me)......... biz.yahscaram(o)uche-10/27/2008
2240Incyte's JAK Inhibitor Demonstrates Rapid and Marked Clinical Improvement inscaram(o)uche-10/27/2008
2239jmp presentation 10/6/08 first line was a one-liner: “ tough time; incy would bsoftware salesperson-10/6/2008
2238nice, thanks! (eom)scaram(o)uche-9/18/2008
2237Friedman’s remarks about competitive oral compounds for MF and/or RA from last wsoftware salesperson-9/18/2008
2236>> in order to be a winner, 18424 will have to be shown to have << scaram(o)uche-9/18/2008
2235i don't think that these results demonstrate anything encouraging. althougsoftware salesperson-9/18/2008
2234<i>(news feed says that Goldman started incy at a buy today....)</i>scaram(o)uche-9/18/2008
2233<Second, the modest slide in after hours is transient, and will be gone over Biotech Jim-8/7/2008
2232I have two thoughts on this. The first relates to when the price was set, I suBiotech Jim-8/6/2008
2231That's correct. So if the price and all other terms were known well beforehatom pope-8/6/2008
2230$9.00 a share was what I had heard. The price was probably set before the rise,Biotech Jim-8/6/2008
2229I wonder what there was in the terms of the secondary to cause the After Hours stom pope-8/6/2008
2228Not huge volume, but nice little rise today. I have an interest because I pushetom pope-8/6/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News